Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	329.26	184.6	412.39	776.42	173.87	152.33
Short-Term Investments	-	0.93	0.86	0.83	0.8	0.77
Cash & Short-Term Investments	329.26	185.53	413.25	777.25	174.67	153.09
Cash Growth	-14.29%	-55.10%	-46.83%	344.99%	14.09%	-55.34%
Accounts Receivable	438.51	376.06	337.32	340.3	258.11	124.38
Other Receivables	-	71.37	87.74	51.89	34.08	31.49
Receivables	438.51	447.43	425.06	392.2	292.25	155.93
Inventory	356.24	339.49	351.82	332.98	192	107.65
Other Current Assets	9.02	9.35	12.72	12.78	7.7	0.61
Total Current Assets	1,133	981.8	1,203	1,515	666.61	417.28
Property, Plant & Equipment	1,178	1,150	929.27	880.77	457.32	255.39
Long-Term Investments	97.69	134.04	43.37	9.35	10.12	-
Goodwill	477.85	477.85	477.85	477.85	22.16	22.16
Other Intangible Assets	202.85	204.46	197.36	167.79	55.1	48.58
Long-Term Deferred Tax Assets	19.85	20.17	15.91	9.81	8.98	3.38
Other Long-Term Assets	90.42	52.16	85.75	29.52	106.76	9.5
Total Assets	3,200	3,021	2,952	3,090	1,327	756.33
Accounts Payable	363.14	184.6	200.52	193.79	69.65	58.49
Accrued Expenses	0.93	46.03	47.06	34.74	15.92	11.69
Short-Term Debt	173.87	79.91	46.34	48.73	131.01	11.01
Current Portion of Long-Term Debt	62	55.2	54.43	72.51	35.62	15.53
Current Portion of Leases	30.43	26.64	38.89	30.46	0.57	0.64
Current Income Taxes Payable	18.58	11.84	4.11	25.18	14.8	8.4
Current Unearned Revenue	-	4.59	-	-	-	-
Other Current Liabilities	26.6	117.47	87.39	92.55	68.06	54.58
Total Current Liabilities	675.55	526.29	478.75	497.95	335.63	160.35
Long-Term Debt	156.34	167.19	205.46	319.61	187.06	90.91
Long-Term Leases	75.53	65.5	54.83	67.69	1.9	2.47
Long-Term Deferred Tax Liabilities	56.95	58.22	59.21	55.33	3.53	7.62
Other Long-Term Liabilities	9.57	8.32	3.66	2.14	-	-
Total Liabilities	1,017	866.4	834.65	973.86	543.54	269.89
Common Stock	302.67	302.67	186.26	186.26	149.01	103
Additional Paid-In Capital	1,498	1,498	1,498	1,498	492.09	304.98
Retained Earnings	158.35	132.41	225.25	238.26	116.85	58.16
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7	3.7
Total Common Equity	1,963	1,937	1,913	1,926	761.64	469.85
Minority Interest	220.1	217.4	204.53	190.25	21.86	16.59
Shareholders' Equity	2,183	2,154	2,118	2,116	783.5	486.44
Total Liabilities & Equity	3,200	3,021	2,952	3,090	1,327	756.33
Total Debt	498.17	394.45	399.95	539	356.17	120.57
Net Cash (Debt)	-168.9	-208.92	13.3	238.25	-181.5	32.53
Net Cash Growth	-	-	-94.42%	-	-	-90.25%
Net Cash Per Share	-0.28	-0.35	0.02	0.45	-0.38	0.07
Filing Date Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Total Common Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Working Capital	457.48	455.51	724.1	1,017	330.98	256.93
Book Value Per Share	3.24	3.20	3.16	3.18	1.57	1.00
Tangible Book Value	1,282	1,254	1,238	1,281	684.38	399.11
Tangible Book Value Per Share	2.12	2.07	2.05	2.12	1.41	0.85
Land	-	333.9	327.63	327.63	183.25	117.3
Buildings	-	534.98	430.08	404.55	177.13	66.64
Machinery	-	379.84	346.66	310.51	148.3	105.7
Construction In Progress	-	174.85	57.17	15.97	0.33	1.1

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.